A prospective randomized open study comparing goserelin (Zoladex) plus surgery and surgery alone in the management of ovarian endometriomas

Wiley - Tập 10 Số 3 - Trang 151-157 - 2001
Robert W. Shaw1, Ray Garry1, Lindsay McMillan1, Chris Sutton1, Simon Wood1, Robert F. Harrison1, Rajiv Das1
11 Department of Obstetrics and Gynaecology, Heath Park, Cardiff, UK 2 South Cleveland Hospital, Middlesbrough, UK 3 Whipps Cross Hospital, London, UK 4 Royal Surrey County Hospital, Guildford, UK 5 formally of Royal Devon and Exeter Hospital, Exeter, UK 6 Rotunda Hospital, Dublin, Eire 7 AstraZeneca, Macclesfield, UK

Tóm tắt

ObjectiveTo determine whether goserelin (ZoladexTM; AstraZeneca, London, UK), plus surgery offers advantages over surgery alone in the management of ovarian endometriomas.DesignProspective, multicentre, randomized, open‐label, parallel‐group study.InterventionsFollowing preoperative aspiration of endometriomas, they were sized by ultrasound, a diagnosis of endometriosis confirmed by laparoscopy and its severity assessed. Patients were stratified according to endometrioma size and randomly allocated to one of two groups: group 1 (G1; n = 21) received a monthly (every 28 days) subcutaneous injection of goserelin 3.6 mg for 3 months (12 weeks); group 2 (G2; n = 27) received no treatment. At 3 months, the size of endometriomas was reassessed in both groups before definitive excision. Both groups were reassessed at 6 months postsurgery.Main outcome measuresChange in size of the largest endometrioma from entry to just prior to excision.ResultsThe mean change in endometrioma size was −2.29 cm in G1 and −1.29 cm in G2. The resulting (adjusted) mean difference of −1.25 cm was statistically significant in favour of G1 (P = 0.036, 95% CI −2.42 to −0.08 cm). Very difficult surgery was reported in four (22%) patients in G1 and 10 (46%) patients in G2. Mean duration of surgery was 74.2 min in G1 and 86.4 min in G2. There was a trend towards a greater reduction in mean Additive Diameter of Implants (ADI) score at 6 months postsurgery in G1 compared with G2 (−65.9 vs. −56.6). Both groups were comparable in terms of the number of complete excisions of their endometrial cysts at surgery, blood loss at surgery, Revised American Fertility Society (R‐AFS) scores and pelvic symptoms. Goserelin was well tolerated.ConclusionsLaparoscopic aspiration of endometriomas followed by a monthly goserelin 3.6 mg depot for 3 months compared with laparoscopic aspiration alone results in significantly smaller endometriomas at 3 months and a trend towards a greater reduction in ADI score.

Từ khóa


Tài liệu tham khảo

Donnez J, 1990, LHRH Analogues in Gynaecology., 165

10.1016/S0015-0282(16)56816-2

10.1016/S0015-0282(16)58346-0

10.1016/S0015-0282(16)48430-X

10.3109/00016348409156982

10.1016/S0015-0282(16)60783-5

Vercellini P, 1992, Laparoscopic aspiration of ovarian endometriomas, effect with post operative gonadotropin releasing hormone agonist treatment, Journal of Reproductive Medicine, 37, 577

10.1111/j.1479-828X.1992.tb01931.x

10.1016/S0015-0282(16)55274-1

Canis M, 1992, Fertility following laparoscopic management of benign adnexal cysts, Human Reproduction, 7, 529, 10.1093/oxfordjournals.humrep.a137684

Thông tin
Thông tin xuất bản

Wiley

Tập 10 Số 3

151-157

Thông tin tác giả